Alexandra Schnell

Title: Innovations by Alexandra Schnell

Introduction

Alexandra Schnell is an accomplished inventor based in Boston, MA. She has made significant contributions to the field of immunology, particularly in understanding and modulating tissue-specific TH17 cell pathogenicity. Her work has implications for therapeutic treatments and diagnostic methods.

Latest Patents

Alexandra Schnell holds a patent titled "Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity." This patent focuses on the tissue-specific modulation of TH17 differentiation and pathogenicity by targeting specific gene programs and gene targets. The therapeutic applications of this work aim to treat diseases or conditions in the tissues where they arise. Additionally, the patent addresses methods for detecting tissue-specific TH17 cells for both diagnostic and therapeutic purposes.

Career Highlights

Throughout her career, Alexandra has worked with prestigious institutions, including Dana-Farber Cancer Institute and Brigham and Women's Hospital. Her research has contributed to advancements in cancer treatment and immunology.

Collaborations

Some of her notable coworkers include Meromit Singer and Aviv Regev, who have also made significant contributions to the field of biomedical research.

Conclusion

Alexandra Schnell's innovative work in modulating TH17 cell pathogenicity showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic approaches and diagnostic methods in immunology.